CANCELLED: 19th ESO-ESMO Masterclass in Clinical Oncology

On behalf of ESO and ESMO we would like to inform you that due to the ongoing Coronavirus (COVID-19) crisis we have made the difficult decision to cancel the 19th ESO-ESMO Masterclass in Clinical Oncology programmed for 21st to 26th March in Seva (Barcelona area), Spain.

We deeply regret having to take this decision but we feel that in the current climate we all need to do our part in trying to limit the diffusion of the virus as much as possible and this was the only decision possible considering your role in society as medical staff.

We have discussed the possibility of postponing the event to later this year, but due to other already planned activities we have decided that postponing is not a viable solution.

We apologize for any inconvenience caused but we think you’ll all agree that this solution was unavoidable.

Chairs: N. Pavlidis, GR - R.A. Stahel, CH
Scientific Advisors: F. Lordick, DE - R. Popescu, CH


AIMS AND OBJECTIVES
This clinically oriented educational programme has been designed for medical or clinical oncologists who wish to improve their skills or those who are preparing for the national board exam.
The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-oriented training. The programme focuses on breast, gastro-intestinal, lung, genito-urinary, gynaecological, head and neck cancers.
Spotlight sessions will facilitate compact update on mentorship, cancer of unknown primary, molecular tumour board (including liquid biopsy), cultural diversity, basic public speaking, immuno-oncology, melanoma, nutrition, neuroendocrine tumours, burn-out syndrome, early integration in oncology and palliative care, fertility presentation and pregnancy in cancer patients, brain tumours, mind body medicine.

TEACHING FORMAT
The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will conclude in take-home messages. Participants will deliver case presentations within tumour boards and small groups and discuss them with the chairmen and the faculty. Informal discussion will be facilitated during the lunches and the aperitifs with the experts.
All participants will reside at the course venue and participation is compulsory throughout the course.
The Masterclass will be entirely in English and fluency in English is necessary for admission.
Participants of the concomitant Masterclass in Nursing Oncology will attend selected medical sessions whilst the communication skills sessions will be attended jointly.

THE MASTERCLASS IS
• A 5-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering lectures focusing on genito-urinary, breast, gynaecological, head and neck, gastro-intestinal and lung cancers.

The Masterclass in Clinical Oncology is an ESO-ESMO joint event
The Masterclass is held in collaboration with the Flims Alumni Club
The 2020 Masterclass is part of the Masterclass-Online Study Program in Advanced Oncology of the University of Ulm

 

In this review, the authors summarize the history of the 41 Masterclasses in Clinical Oncology (MCO) organized by ESO or ESO-ESMO during the last 17 years. The MCO has become a major educational event of ESO, intending to educate young oncologists from various countries within or outside Europe, providing an up-to-date interactive program based on solid evidence for all presented topics.
"Reprinted from Critical Reviews in Oncology / Hematology, Pavlidis et al, Copyright (2019)
https://doi.org/10.1016/j.critrevonc.2019.07.022 with permission from Elsevier”

• Download PDF document

INVITED FACULTY
A. Aapro, Clinique de Genolier, CH
A. Arber, University of Surrey, Faculty of Health and Medical Sciences, Guildford, UK
J. Arends, Freiburg University Hospital, Freiburg, DE
S. Banerjee, The Royal Marsden NHS Trust Foundation, London, UK
G. Curigliano, European Institute of Oncology, Milan, IT
M. De Santis, Charité University Hospital, Berlin, DE
A. Dietz, University Hospital Leipzig, Leipzig, DE
A. Eggermont, Princess Máxima Center for Pediatric Oncology, Utrech, NL
A. Eniu, Cancer Institute "Ion Chiricuta", Cluj-Napoca, RO
K. Fizazi, Institut Gustave Roussy, Villejuif (Paris), FR
T. Gagliardi, Royal Marsden Hospital, London, UK
W. Gatzemeier, Humanitas Cancer Center, Rozzano, IT
D. Hart, Cameron Communications, London, UK
S. Hillinger, University Hospital, Zurich, CH
A. Hoy, Consultant in Palliative Medicine, Epson, UK
S. Joosse, University Medical Center Hamburg-Eppendorf, Hamburg, DE
N. Koppotsch, Charité University Hospital, Berlin, DE
A. Letsch, Universitätsklinikum Schleswig-Holstein, Kiel, DE
F. Lordick, University Hospital Leipzig, University Cancer Center, Leipzig, DE
F. Mc Donald, The Royal Marsden NHS Foundation Trust, London, UK
R. Orecchia, European Institute of Oncology, Milan, IT
O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
N. Pavlidis, University Hospital of Ioannina, Ioannina, GR
F.A. Peccatori, European Institute of Oncology, Milan, IT
M. Pera, Universitat Autónoma de Barcelona, Barcelona, ES
R. Popescu, Hirslanden Klinik Aarau, Tumor Center, Aarau, CH
G. Pruneri, University of Milan – European Institute of Oncology, Milan, IT
M. Schumacher, Hirslanden Klinik Aarau, Aarau, CH
C. Sessa, Oncology Institute of Southern Switzerland, Bellinzona, CH
L. Sharp, Regional Cancer Centre, Stockholm, SE
R.A. Stahel, University Hospital, Zurich, CH
C. Toumpanakis, Royal Free Hospital, London, UK
E. Van Cutsem, University Hospital Leuven, Leuven, BE
R. Verity, King's College London, London, UK
J.B. Vermorken, Antwerp University Hospital, Edegem, BE
M. Weller, University Hospital Zurich, Zurich, CH
C. Witt, University Hospital Zurich and University of Zurich, Zurich, CH
I. Zapardiel, La Paz University Hospital, Madrid, ES

ORGANISING SECRETARIAT                       
Alice Ciocchini                            
Ph: +39 02 85464529                           
Email: aciocchini@eso.net                         
European School of Oncology
Via Turati, 29
20121 Milan, Italy
Fax: +39 02 85464545

Applications
Corinne Hall
Ph: +39 02 85464522
Email: chall@eso.net

ACCREDITATION
Application for CME recognition will be submitted to the European Society for Medical Oncology (ESMO) for ESMO-MORA accreditation, to the Accreditation Council of Oncology in Europe (ACOE) and to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the applications can be obtained from the organising secretariat.

SOCIAL MEDIA
Follow updates, send questions and join in the discussions using #20MCO on Twitter and Facebook.

IDEAL MASTERCLASS CANDIDATE
• Age between 30 and 40 years
• At least 2-3 years’ experience in medical oncology or clinical oncology
• Involvement in scientific activities
• Fluency in English

ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY
Successful applicants are granted free registration and accommodation
THE APPLICATION DEADLINE HAS PASSED (1 DECEMBER 2019)

21 March

 22 March

 23 March

 24 March

 25 March

 26 March